发明名称 |
Antibody-light fusion products for cancer therapeutics |
摘要 |
Antibody-LIGHT fusion products or conjugates stimulate immunity against tumors and eradicate metastases. Tumor-specific antibodies coupled with LIGHT effectively target metastatic tumors and reduces cancer metastases. |
申请公布号 |
US9623116(B2) |
申请公布日期 |
2017.04.18 |
申请号 |
US201514717808 |
申请日期 |
2015.05.20 |
申请人 |
The University of Chicago |
发明人 |
Fu Yang-Xin |
分类号 |
A61K39/00;A61K39/395;A61K47/48;C07K14/525;A61K31/7088;A61K38/19 |
主分类号 |
A61K39/00 |
代理机构 |
Casimir Jones SC |
代理人 |
Casimir Jones SC ;Staple David |
主权项 |
1. A method of reducing the growth of a primary tumor or cancer metastasis in a subject in need thereof, the method comprising:
(a) administering to the subject a composition comprising a tumor specific antibody linked to a fragment of a human LIGHT protein to the subject, wherein the LIGHT fragment is resistant to protease digestion and is sufficient to stimulate tumor specific cytotoxic T lymphocytes against the tumor cells; (b) delivering a nucleic acid molecule encoding LIGHT or a fragment thereof to the primary tumor; and (c) stimulating the tumor-specific cytotoxic T-lymphocytes against the tumor or its metastases to reduce to the growth of the primary tumor or cancer metastasis. |
地址 |
Chicago IL US |